ArticleJournal of education and health promotion2026
Intervention of pharmaceutical care on the quality-adjusted life years in diabetic foot ulcer patients-A randomized controlled study.
Article in Journal of education and health promotion, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiabetic foot ulcer (DFU) is one of the reasons for hospitalization among diabetic patients. The objective is to study the impact of pharmaceutical care on quality-adjusted life years (QALY) in DFU patients. MATERIALS AND
methodsThe eligible DFUs patients were randomized into the General Care (GC) and Pharmaceutical Care (PC) Group in a 1:1 ratio using the block design method. The study was carried out for 2 years at a tertiary care teaching hospital. The PC group received pharmaceutical care from the clinical pharmacist along with general care. The sociodemographics, health-related quality of life (HRQoL), and economic data were collected from the both groups at baseline, 6
resultsOut of 174 DFU patients, 87 each were allocated to PC and GC groups. At baseline, there was no statistically significant difference in HRQoL scores; in contrast, during 6
conclusionThe clinical pharmacist who provided structured pharmaceutical care services had significant positive impact on the HRQoL and economic outcomes in the PC group compared to the GC group. The study intervention was cost effective based on India's GDP per capita of 2022.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.